Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 34.08
-1.54 (-4.32%)
Jul 30, 2026, 11:59 AM HKT
HKG:6855 Market Cap
HKG:6855 has a market cap or net worth of 13.1 billion as of July 29, 2026. Its market cap has decreased by -53.91% in one year.
Market Cap
13.10B
Enterprise Value
12.56B
Revenue
638.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
34.08
ChartMarket Cap Chart
Since October 28, 2019, HKG:6855's market cap has increased from 7.59B to 13.10B, an increase of 72.68%. That is a compound annual growth rate of 8.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 13.10B | -31.87% |
| Dec 31, 2025 | 19.23B | 36.66% |
| Dec 31, 2024 | 14.07B | 81.16% |
| Dec 29, 2023 | 7.77B | 17.12% |
| Dec 30, 2022 | 6.63B | -8.70% |
| Dec 31, 2021 | 7.26B | -14.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Duality Biotherapeutics | 20.56B |
| Zai Lab | 16.42B |
| Metis TechBio | 12.97B |
| GenFleet Therapeutics (Shanghai) | 12.29B |
| Nanjing Leads Biolabs | 11.55B |
| HBM Holdings | 10.95B |
| Shaanxi Micot Pharmaceutical Technology | 10.48B |
| Ascletis Pharma | 9.73B |